ZYBERNO
Stock Report
Updated Jun 10, 2026

CNL Healthcare Properties, Inc. (CHTH)

Financial Services • Over The Counter

$5.00

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
17.0/100
POOR BUSINESS
CNL Healthcare Properties, Inc. (CHTH) scores 17/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
MARGIN OF SAFETY
Is this stock cheap or expensive relative to what the business has historically generated for owners?
Margin of Safety unavailable — insufficient data for the owner-earnings DCF.
Is the market underestimating or overestimating what this business is capable of going forward?
-28.6%
Market Overestimates
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-1.5%)
Debt-to-Equity (Solvency Risk):AVERAGE (0.81x)
Operating Margin (Operational Efficiency):AVERAGE (8.8%)
Return on Capital (Capital Efficiency):CRITICAL (1.4%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

CNL Healthcare Properties, Inc. (CHTH) stock report — Zyberno Score 17/100 (POOR BUSINESS). Full financial analysis on Zyberno.

According to Zyberno's DCF model, CNL Healthcare Properties, Inc. (CHTH) shows a Brina Gap of -28.6%, which weakens the case: based on the company's ROIC (1.4%) and reinvestment rate (-199.7%), the business can fundamentally grow at -2.9% — but the current enterprise value implies the market expects 25.7%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:5.00
Market Cap:$869.71M

Valuation Multiples (3)

P/B Ratio:1.25x
P/S Ratio:2.26x
Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$1.94B
Ev Ebitda Ratio:22.70x
B. Profitability Assessment

Return Metrics (7)

ROA:-0.8%
Reinvestment Rate:-199.7%
Fundamental Growth Rate (g):-2.9%
Market-Implied Growth Rate:25.7%

Margin Analysis (3)

Operating Margin Ttm:8.8%
Net Margin Ttm:-2.7%
Ebitda Margin:22.2%

TTM Performance (2)

Operating Margin Ttm:8.8%
Net Margin Ttm:-2.7%

Yield Metrics (2)

Earnings Yield:-$1.00
Dividend Yield:2.1%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-650.0%
Latest Earnings Filed:2025-11-13

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):6.9%

Cash Flow Growth (Linear) (1)

Operating Cash Flow Growth Rate (Linear):-0.9%

Operating Growth (Linear) (1)

Operating Income Growth Rate (Linear):81.9%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.09x
Quick Ratio:0.09x
Cash Ratio:0.09x

Leverage Analysis (3)

Debt To Equity Ttm:0.81x
Debt-to-Equity Ratio:0.81x
Debt To Ebitda:13.21x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:-550,433,000.00
Cash And Cash Equivalents:57,696,000.00
Long Term Debt:$565.00M
Net Debt:$1.07B
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $385.50M
Linear Growth: 6.9%
📊 Click to view full CHTH Revenue analysis & methodology →
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00
Operating income TTM: $33.84M
Linear Growth: 81.9%
📊 Click to view full CHTH Operating Income analysis & methodology →

Bottom Line Performance (3)

-$10.59M
Income Before Tax:-$9.84M
Ebitda Ttm:85,554,000.00

Operating Expenses (5)

Operating Expenses:351,655,000.00
R And D Expense:0.00
Sga Expense:9,562,000.00
Income Tax Expense:$745.00K
Interest Expense:0.00

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:9.6%
Ebitda Margin:22.2%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$1.30B
Current Assets:$57.70M
Ppe Net:0.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:608,129,000.00
Current Liabilities:608,129,000.00
Long Term Debt:$565.00M
Short Term Debt:$565.00M

Equity & Capital (3)

Equity:$693.61M
Retained Earnings:$54.61M
Common Stock:1,120,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:0.00
Accounts Payable:32,143,000.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: $47.44M
Linear Growth: -86.0%
$0.00

Investment Activities (1)

Investing Cash Flow:-$2.26M

Financing Activities (3)

Financing Cash Flow:-$4.34M
Dividends Paid Ttm:17,812,000.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:51,714,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.05
-$0.05
Earnings Per Share Ttm:-$0.06

Revenue & Cash Per Share (2)

Sales Per Share Ttm:2.22
Operating Cash Flow Per Share:$0.23

Book Value & Capital (2)

Book Value Per Share:$3.99
Cash Per Share:0.33

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.29x
Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:30.43
Cash Conversion Cycle:-2,028.43
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:0.00
Quality Score:30.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (4)

Reinvestment Rate:-199.7%
Fundamental Growth Rate (g):-2.9%
Market-Implied Growth Rate:25.7%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (2)

Revenue Growth Rate (Linear):6.9%
Operating Income Growth Rate (Linear):81.9%

Cash Flow Growth Rates (1)

Operating Cash Flow Growth Rate (Linear):-0.9%

Other Growth Rates (1)

Book Value Growth Rate (Linear):-4.7%
C. Company Profile & Context

Corporate Information (6)

Symbol:CHTH
Company Name:CNL Healthcare Properties, Inc.
Sector:Financial Services
Industry:Real Estate
Exchange:Over The Counter
Country:Unknown

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:173.94M
Shares Outstanding Basic:173.94M
Shares Outstanding Diluted:173.94M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-06-10 14:05:48 UTC
Data Timestamp:2026-06-10T14:05:48.705009
Scroll to Top